Today the #EURETINA2021 Virtual Congress starts. Take this opportunity and check out the contributions from the #MACUSTAR consortium

Macular disease is the biggest cause of sight loss in the UK. It affects people of all ages. There is no cure but there are things you can do to look after your eyes. Our free eye health pack provides practical tips #EyeWeek #EyeHealth #VisionMatters macularsociety.org/support/free-e…

Nearly 1.5m people in the UK are living with macular disease. It is the biggest cause of sight loss in the UK. We must find a cure #WorldSightDay

The EMA issued a second letter of support for MACUSTAR! The letter of support is published on the MACUSTAR website under the following link: macustar.eu/press-media/pr… and on the EMA website: ema.europa.eu/en/documents/o…

Please find a new event „Horizont Europa für NRW - die digitale Messe“ on 17.05 and register until 13.05. horizont.zenit.de/events/eroffnu…

Dear all, thank you again for participating the MACUSTAR Investigator Meeting during EURETINA in Hamburg! euretina.org/hamburg2022/ha…

Get your dose of poster and paper presentations showcasing the results from the #MACUSTAR study at #ARVO2023. #AMD

Scientific Advisory Board Meeting during #ARVO2023 Thank you all for a constructive meeting and for fruitful discussions!

Looking back to this year´s exciting 7th MACUSTAR General Assembly meeting in Bonn. Very fruiful discussions on 8 different presentations covering the different MACUSTAR workgroups- so much collaborative high quality work going on!

🎙️ New #EURETINA Podcast Ep 48: Assessing Visual Deficits in Intermediate AMD. Prof. Frank Holz & Dr. Hannah Dunbar dive into findings from the Macustar trial, offering insights into patient care and strategies. 🎧 Listen: ow.ly/r0qX50RuCAx #AMD #Macustar

Find the most recent exciting results from MACUSTAR project at ARVO 2024- looking forward to seeing you there

New MACUSTAR publication! 👁️"Generalizable Deep Learning for the Detection of Incomplete and Complete Retinal Pigment Epithelium and Outer Retinal Atrophy-A MACUSTAR report" Advancing AI-driven precision in retinal disease detection! Read more: tvst.arvojournals.org/article.aspx?a…

Don´t miss the latest MACUSTAR findings at EURETINA 2024 in Barcelona. Looking forward to seeing you there!

We are looking back to a successful MACUSTAR General Assembly meeting 2024 in Bonn: Milestones, scientific output, and regulatory strategy were reviewed and discussed. We engaged in many productive conversations about strategies for managing this remarkable project's future!

EMA encourages further conduct of MACUSTAR project with 3rd Letter of Support! Read the full letter here: ema.europa.eu/en/documents/o…

Ein neuer Meilenstein für MACUSTAR: Das Projekt hat von der Europäischen Arzneimittelagentur (EMA) ein drittes Unterstützungsschreiben erhalten! linkedin.com/posts/macustar…

MACUSTAR has achieved a new milestone! europe.ophthalmologytimes.com/view/macustar-…

Check out the new MACUSTAR publication for fresh insights and discoveries on candidate endpoints in iAMD trials! nature.com/articles/s4143…

MACUSTAR is presenting at ARVO this week! Check out our new project publications. 📚 #AMD #Retina

New publication from the MACUSTAR study! We show that relative ellipsoid zone reflectivity (rEZR) on OCT is associated with the different metrics of retinal function in AMD —supporting rEZR as a structural biomarker of retinal integrity. nature.com/articles/s4159…